Fragment-to-Lead Medicinal Chemistry Publications in 2018-Reference-Cited by-同舟云学术

Fragment-to-Lead Medicinal Chemistry Publications in 2018

Published:2020-01-08 Issue:9 Volume:63 Page:4430-4444
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Erlanson Daniel A.¹^ORCID,de Esch Iwan J. P.²,Jahnke Wolfgang³^ORCID,Johnson Christopher N.⁴^ORCID,Mortenson Paul N.⁴^ORCID

Affiliation:

1. Frontier Medicines, 151 Oyster Point Boulevard, South San Francisco, California 94080, United States

2. Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands

3. Novartis Institutes for Biomedical Research, Chemical Biology and Therapeutics, 4002 Basel, Switzerland

4. Astex Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b01581

Reference70 articles.

1. Twenty years on: the impact of fragments on drug discovery

2. Fragment-to-Lead Medicinal Chemistry Publications in 2015

3. Fragment-to-Lead Medicinal Chemistry Publications in 2016

4. Fragment-to-Lead Medicinal Chemistry Publications in 2017

5. Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Site Identification and Next Choice Protocol for Hit-to-Lead Optimization;Journal of Chemical Information and Modeling;2024-05-20

2. Fragment-to-Lead Medicinal Chemistry Publications in 2022;Journal of Medicinal Chemistry;2024-01-30

3. Fragment library screening by X-ray crystallography and binding site analysis on thioredoxin glutathione reductase of Schistosoma mansoni;Scientific Reports;2024-01-18

4. Fragment-based drug discovery campaigns guided by native mass spectrometry;RSC Medicinal Chemistry;2024

5. Advances in analytical technologies detecting and characterizing noncovalent interactions for fragment-based drug discovery;TrAC Trends in Analytical Chemistry;2023-09